ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Incyte Genomics Inc. (INCY)

NASDAQ

$106.25

$+3.11

(+3.03%)

Incyte Genomics Inc. (INCY) Live Price Chart

Page last updated: 2026-02-06 15:20:28

Key Market Data

Market Cap	$20.86B
Open	$103.75
High	$153.15
Low	$1.85
Previous Close	$102.76
Price Change	$+3.11
Percentage Change	+3.03%
Volume	486K

Incyte Genomics Inc. (INCY) Stock Price Today

Incyte Genomics Inc. (INCY) is currently trading at $106.25 as of 2026-02-06 15:20:28, reflecting a +3.03% move ($+3.11) from the previous close.

In the short term, the stock has returned +31.16% over the past four weeks. Over the last 12 months, Incyte Genomics Inc. has recorded a +41.76% price change, indicating a strong performance relative to the broader market.

Incyte Genomics Inc. (INCY) 7-Day Stock Price Changes

Over the past seven days, Incyte Genomics Inc. has traded within a short-term range shaped by market sentiment in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. During this period, the stock moved from its previous closing price of $99.75 to the latest recorded price of $106.25, reflecting an intraday change of +3.03%. Daily movements highlight shifts in trading volume (486,409), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, INCY has delivered a +31.16% return over the past month and a +41.76% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Incyte Genomics Inc. (INCY)

You can buy and trade INCY on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for INCY and Execute Your Trade

Open the trading page, enter INCY in the search bar, select the amount of INCY you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Incyte Genomics Inc. (INCY)?

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Incyte Genomics Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	2,617
Sector	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Company Website	https://www.incyte.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Incyte Genomics Inc.?

The latest trading price for Incyte Genomics Inc. (Common Stock) is $ 106.25, compared with a previous closing price of $ 102.76. That means the stock has moved +3.03% so far today. Intraday price updates and recent trading activity for INCY can be tracked on the live chart and quote section on this page.

2.Is Incyte Genomics Inc. stock going up or down?

Looking at recent performances, INCY has returned +31.16% over the past month, +34.17% over the last six months and +41.76% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Incyte Genomics Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does INCY currently sit relative to its 52-week high and low?

In the most recent 52-week period, Incyte Genomics Inc. has traded between a low of $ 53.56 and a high of $ 112.29. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether INCY is currently nearer the top or the bottom of its one-year trading band.

4.How is Incyte Genomics Inc. classified by sector and industry?

Incyte Genomics Inc. is classified in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, within the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry group and the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry. In practice, this means Incyte Genomics Inc. is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing INCY's sector and industry classification helps when building diversified portfolios, comparing Incyte Genomics Inc. with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry.

5.Where is Incyte Genomics Inc. listed and how large is it by market value?

Incyte Genomics Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 20.86B, the company is classified as a Large-cap stock. Market cap gives a quick sense of Incyte Genomics Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does INCY's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ 6.05 summarises how much profit Incyte Genomics Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Incyte Genomics Inc.'s financial performance over time?

To follow Incyte Genomics Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how INCY is performing and how the market is responding.

8.When is Incyte Genomics Inc. expected to report earnings?

Incyte Genomics Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for INCY, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Incyte Genomics Inc.'s earnings reports?

Incyte Genomics Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether INCY is meeting, beating or missing expectations.

10.How can I stay informed about Incyte Genomics Inc.'s results and guidance?

You can stay up to date on Incyte Genomics Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for INCY on this page helps you see how new information is being reflected in the stock.

11.Does Incyte Genomics Inc. pay a regular cash dividend to its shareholders?

Incyte Genomics Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor INCY's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for INCY?

Based on the latest earnings data, INCY has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Incyte Genomics Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Incyte Genomics Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Incyte Genomics Inc.?

Incyte Genomics Inc. is a publicly traded company in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry within the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is INCY valued in terms of P/E ratio and EPS?

Incyte Genomics Inc. currently trades at a price-to-earnings (P/E) ratio of 16.97, based on trailing-twelve-month earnings per share (EPS) of $ 6.05. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Incyte Genomics Inc.'s earnings. Comparing INCY's P/E and EPS to those of other SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Incyte Genomics Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Designer Brands Inc.

DBI

First BanCorp.

FBP

Green Brick Partners, Inc.

HXL

Top Gainers

Browse today's leading gainers in the US stock market

Bio Green Med Solution, Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

INCY-to-USD Calculator

Amount

INCY

USD

1 INCY = 106.25 USD